Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fmr Corp
Relationship:  
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   32    
Direct Shares   0    

Indirect Shares

   55,020,234      
Direct Value   $0    

Indirect Value

   $669,422,061      
Total Shares   55,020,234      
Total Value   $669,422,061      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    5    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    5    
   
     Gain/Loss Ratio :
   0.0   
   -5.0   
     Percentage Gain/Loss :
     0.0%
 -153.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ironwood Pharmaceuticals Inc IRWD Edward C. Johnson 3d, ... 0 2012-07-10 2,340,891    Premium*  
            Exa Corp EXA See Remark 1 2012-07-03 0 2016-09-30 0    Premium*  
            Insmed Inc INSM Edward C. Johnson 3d, ... 0 2013-07-22 2,221    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH See Remark 1 2015-03-05 0 2013-03-25 2,141,645    Premium*  
            GT Advanced Technologies Inc GTAT Edward C. Johnson 3d 0 2014-05-27 1,078,006    Premium*  
            Ultragenyx Pharmaceutical Inc RARE See Remark 1. 2014-01-30 0 2014-08-01 1,457,994    Premium*  
            Generac Holdings Inc. GNRC See Remark 1, 10% Owner 2014-07-01 0 2014-07-01 763,071    Premium*  
            Blueprint Medicines Corp BPMC See Remark 1 2015-05-05 0 2015-11-27 264,898    Premium*  
            Coherus Biosciences, Inc. CHRS See Remark 1 0 2016-08-08 361,594    Premium*  
            Regenxbio Inc. RGNX See Remark 1 0 2016-05-17 489,880    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-13 0 2017-08-11 326,617    Premium*  
            Dimension Therapeutics, Inc. DMTX See Remark 1 0 2017-11-07 0    Premium*  
            Kineta Ord Shs KA See Remark 1 2016-02-17 0 2017-03-13 243,508    Premium*  
            Viewray, Inc. VRAY See Remark 1 0 2018-08-08 606,356    Premium*  
            Mersana Therapeutics, Inc. MRSN See Remark 1 0 2017-07-03 1,715,935    Premium*  
            Cogent Biosciences, Inc. COGT See Remark 1 2018-04-03 0 2018-04-03 23,240    Premium*  
            Surface Oncology, Inc. SURF See Remark 1, 10% Owner 2018-04-23 0 2018-04-23 1,888,986    Premium*  
            Denali Therapeutics Inc. DNLI See Remark 1 2017-12-12 0 2017-12-12 783,216    Premium*  
            VYNE Therapeutics Inc VYNE See Remark 1 2018-01-29 0 2018-01-29 1,118,054    Premium*  
            Precision Biosciences Inc DTIL See Remark 1 2019-04-01 0 2019-04-01 3,738,248    Premium*  
            Orchard Therapeutics Plc ORTX See Remark 1, 10% Owner 0 2021-02-19 4,099,540    Premium*  
            Beam Therapeutics Inc. BEAM See Remark 1 2020-02-10 0 2024-02-14 1,235,511    Premium*  
            Flywire Corp FLYW See Remark 1 0 2021-05-28 14,728,818    Premium*  
            Verve Therapeutics, Inc. VERV See Remark 1, 10% Owner 2021-06-21 0 2022-07-12 570,729    Premium*  
            Caribou Biosciences, Inc. CRBU See Remark 1 2021-07-27 0 2021-07-27 1,464,775    Premium*  
            Rallybio Corp RLYB See Remark 1 2021-08-02 0 2021-08-02 1,694,388    Premium*  
            Xilio Therapeutics, Inc. XLO See Remark 1 0 2021-10-26 30,780    Premium*  
            Prime Medicine, Inc. PRME See Remark 1 2022-10-24 0 2022-10-24 4,228,589    Premium*  
            Structure Therapeutics Inc. GPCR 10% Owner 2023-02-07 0 2023-10-02 785,364    Premium*  
            Turnstone Biologics Corp. TSBX See Remark 1, 10% Owner 2023-07-25 0 2023-07-25 4,939    Premium*  
            Neumora Therapeutics, Inc. NMRA See Remark 1 0 2023-09-19 2,000,018    Premium*  
            Sana Biotechnology, Inc. SANA 0 2024-04-01 4,832,423    Premium*  
* Premium Members only  

Records found :    207         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INSM Insmed Inc Edward C. Johnson 3d   –       –       •   2013-07-15 4 S $10.93 $529,847 I/I (48,472) 5,376 0 -
INSM Insmed Inc Edward C. Johnson 3d   –       –       •   2013-07-16 4 S $10.65 $603,219 I/I (56,652) 4,995 0 -
INSM Insmed Inc Edward C. Johnson 3d   –       –       •   2013-07-17 4 S $11.66 $2,648,809 I/I (227,231) 3,466 0 -
INSM Insmed Inc Edward C. Johnson 3d   –       –       •   2013-07-18 4 S $11.85 $312,126 I/I (26,344) 3,289 0 -
INSM Insmed Inc Edward C. Johnson 3d   –       –       •   2013-07-19 4 S $12.06 $1,279,733 I/I (106,142) 2,575 0 -
INSM Insmed Inc Edward C. Johnson 3d   –       –       •   2013-07-22 4 S $11.96 $629,303 I/I (52,616) 2,221 0 -
GTAT GT Advanced Technologies ... 10% Owner   –       –       •   2013-11-14 3 IO $0.00 $0 I/I 0 1,305,927 -
RARE Ultragenyx Pharmaceutical... Edward C. Johnson 3d   –       –       •   2014-01-30 4 A $0.00 $0 I/I 3,085,240 3,085,240 0 -
RARE Ultragenyx Pharmaceutical... Edward C. Johnson 3d   –       –       •   2014-01-31 4 B $21.00 $3,675,000 I/I 175,000 3,260,240 1.5 -
GTAT GT Advanced Technologies ... 10% Owner   –       –       •   2014-04-04 3 IO $0.00 $0 I/I 0 1,542,777 -
GTAT GT Advanced Technologies ... Edward C. Johnson 3d   –       –      –    2014-05-27 4 S $15.98 $7,425,228 I/I (464,771) 1,078,006 0 -
GNRC Generac Holdings Inc. 10% Owner   –       –       •   2014-06-30 3 IO $0.00 $0 I/I 0 735,903 -
GNRC Generac Holdings Inc. See Remark 1   –       –       •   2014-07-01 4 B $47.04 $1,277,983 I/I 27,168 763,071 1.5 -
RARE Ultragenyx Pharmaceutical... See Remark 1.   –       –      –    2014-08-01 4 D $0.00 $0 I/I (1,802,246) 1,457,994 0 -
TTPH Tetraphase Pharmaceutical... 10% Owner   –       –       •   2015-01-28 3 IO $0.00 $0 D/D 0 671,912 -
TTPH Tetraphase Pharmaceutical... See Remark 1   –       –      –    2015-03-05 4 GD $0.00 $0 D/D 671,912 0 0 -
BPMC Blueprint Medicines Corp See Remark 1   –       –       •   2015-05-05 4 A $0.00 $0 I/I 2,375,711 2,375,711 0 -
BPMC Blueprint Medicines Corp See Remark 1   –       –       •   2015-05-05 4 B $18.00 $2,250,000 I/I 125,000 2,500,711 1.5 -
CHRS Coherus Biosciences, Inc. 10% Owner   –       –       •   2015-08-14 3 IO $0.00 $0 I/I 0 510,194 -
RGNX Regenxbio Inc. 10% Owner   –       –       •   2015-09-22 3 IO $0.00 $0 I/I 0 1,085,816 -
ACRS Aclaris Therapeutics, Inc... See Remark 1   –       –       •   2015-10-13 4 A $0.00 $0 I/I 3,468,824 3,468,824 0 -
ACRS Aclaris Therapeutics, Inc... See Remark 1   –       –       •   2015-10-13 4 B $11.00 $3,690,005 I/I 335,455 3,804,279 1.5 -
DMTX Dimension Therapeutics, I... 10% Owner   –       –       •   2015-10-21 3 IO $0.00 $0 I/I 0 239,479 -
CHRS Coherus Biosciences, Inc. 10% Owner   –       –       •   2015-10-22 3 IO $0.00 $0 I/I 0 510,194 -
DMTX Dimension Therapeutics, I... See Remark 1   –       –       •   2015-10-27 4 A $0.00 $0 I/I 6,760,627 7,000,106 0 -
  207  Records found
  1   2  3   4   5   6   7   8   9      
  Page 2 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us